Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu Christopher C. BenzGary K. ScottC. Kent Osborne Report Pages: 85 - 95
C-erbB-2 protein in the sera of breast cancer patients Tatsuhiko NaritaHiroomi FunahashiHiroshi Takagi Report Pages: 97 - 102
Epitope expression on the breast epithelial mucin Roberto L. CerianiJerry A. PetersonDerek T. A. Lamport Report Pages: 103 - 113
Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas — a 10 year survival study Sven-Börje EwersRobyn AttewellDick Killander Report Pages: 115 - 126
Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate Shengmin LiMartin LepageFernand Labrie Report Pages: 127 - 137
Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen E. Garcia-GiraltY. AymeD. Zylberait Report Pages: 139 - 145
Evaluation of binding of cytotoxic analogs of luteinizing hormone-releasing hormone to human breast cancer and mouse MXT mammary tumor Slobodan R. MilovanovicSinisa RadulovicAndrew V. Schally Report Pages: 147 - 158
Hereditary breast cancer in sweden: a predominance of maternally inherited cases Annika LindblomSam RotsteinLennart Iselius Report Pages: 159 - 165
Lipid-associated sialic acid levels in human breast cyst fluids Ferdinando MannelloGianDomenico BocchiottiGiancarlo Gazzanelli Brief Communication Pages: 167 - 170
